TY - JOUR
T1 - Early Failure of Coronary Artery Bypass Grafts: An Albumin Cross-Linked Glutaraldehyde (BioGlue) Related Complication
AU - Khan, Habib
AU - Chaubey, Sanjay
AU - Desai, Jatin
PY - 2011/5
Y1 - 2011/5
N2 - P>Bioglue which constitutes albumin cross linked with glutaraldehyde (ACLG) produced by Cryolife, Inc, Kennesaw, GA was introduced as a better alternative to GRF glue with less tissue necrosis. We report a case of a 69-year-old male who developed stenosis of his saphenous vein and internal thoracic artery bypass grafts, requiring re-do coronary artery bypass grafting. Both fibrotic narrowing were in close proximity to the site of Bioglue application and appears to be a reaction to the glue. The advent of ACLG has facilitated surgery; however, this case highlights a potential side effect, emphasizing the judicious use of this hemostatic agent in patients. (J Card Surg 2011;26:264-266).
AB - P>Bioglue which constitutes albumin cross linked with glutaraldehyde (ACLG) produced by Cryolife, Inc, Kennesaw, GA was introduced as a better alternative to GRF glue with less tissue necrosis. We report a case of a 69-year-old male who developed stenosis of his saphenous vein and internal thoracic artery bypass grafts, requiring re-do coronary artery bypass grafting. Both fibrotic narrowing were in close proximity to the site of Bioglue application and appears to be a reaction to the glue. The advent of ACLG has facilitated surgery; however, this case highlights a potential side effect, emphasizing the judicious use of this hemostatic agent in patients. (J Card Surg 2011;26:264-266).
U2 - 10.1111/j.1540-8191.2011.01208.x
DO - 10.1111/j.1540-8191.2011.01208.x
M3 - Editorial
VL - 26
SP - 264
EP - 266
JO - Journal of Cardiac Surgery
JF - Journal of Cardiac Surgery
IS - 3
ER -